Voya Investment Management LLC Tcr2 Therapeutics Inc. Transaction History

Voya Investment Management LLC

  • $79.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.11 - $2.94 $23,294 - $32,457
-11,040 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$4.58 - $8.34 $2,615 - $4,762
-571 Reduced 4.92%
11,040 $51,000
Q1 2021

May 17, 2021
BUY
$20.38 - $34.07 $12,248 - $20,476
601 Added 5.46%
11,611 $256,000
Q4 2020

Feb 16, 2021
BUY
$19.0 - $32.63 $209,190 - $359,256
11,010 New
11,010 $341,000

About TCR2 THERAPEUTICS INC.

TCRR Quotes by TradingView
  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email